An observational study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasis.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28989

Enrollment

Registered

2007-09-19

Start date

2006-10-30

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Fatigue (moeheid)

Interventions

None, this is an observational study.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who start with etanercept or UVB therapy (control group) for psoriasis. 2. Patients who have a PASI > or = 10.

Exclusion criteria

Exclusion criteria: 1. Patients who have another active disease which is known to cause fatigue; 2. Patients who use therapeuticals which are known to cause fatigue; 3. Unability to comply with study procedures, like filling in questionnaires in Dutch.

Design outcomes

Primary

Measure	Time frame
The results of fatigue specific questionnaires.	—

Contacts

Public ContactL.L.A. Lecluse

Meibergdreef 9,

onderzoeksteamhuidziekten@amc.uva.nl++31 20 5662530

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)